a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies.
Industry MedicalSpecialties
A.I.dvisor tells us that PSNL and ICUI have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PSNL and ICUI's prices will move in lockstep.
Ticker / NAME | Correlation To PSNL | 1D Price Change % | ||
---|---|---|---|---|
PSNL | 100% | -9.47% | ||
ICUI - PSNL | 31% Poorly correlated | -1.63% | ||
NVST - PSNL | 29% Poorly correlated | -1.28% | ||
BNGO - PSNL | 29% Poorly correlated | -7.58% | ||
MASS - PSNL | 29% Poorly correlated | +1.71% | ||
SIBN - PSNL | 28% Poorly correlated | -5.33% | ||
More |
Ticker / NAME | Correlation To PSNL | 1D Price Change % |
---|---|---|
PSNL | 100% | -9.47% |
Medical Specialties industry (417 stocks) | 27% Poorly correlated | -1.54% |
Medical Specialties industry (427 stocks) | 27% Poorly correlated | -1.35% |